Vitamin D Levels and Postoperative Pain in Laparoscopic Cholecystectomy
NCT ID: NCT04687527
Last Updated: 2021-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2020-05-15
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Vitamin D has been associated with chronic non-specific musculoskeletal pain and migraines due to anti-inflammatory effects.
This prospective observational study will undergo elective laparoscopic cholecystectomy surgery between 18 and 65 years, is planned to participate in ASA (American Society of Anesthesiologists) 1-3, 90 volunteer patients.
In preoperative evaluation, the remaining 3 ml of blood was centrifuged from the routine received blood to determine the level of vitamin D will be kept.
Postoperative will be applied to patient controlled analgesia to all patients for 24 hours.
To determine the level of postoperative pain, the visual analog scale (VAS) will be used in the clock unit and at the service 6, 12 and 24 hours.
In this study, the investigators aimed to test the hypothesis of relation to pain and opioid consumption in acute postoperative (24 hours) of perioperative low-vitamin D.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin C Efficacy in Reducing Post Operative Pain
NCT01322061
Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy
NCT02553551
Analgesic and Anti-inflamatory Effect of Vit. B
NCT06857734
Liver Cauterization Increases the Postoperative Pain After Laparoscopic Cholecystectomy
NCT02852408
Relationship Between Acute Phase Markers and Post-operative Pain in Laparoscopic Cholecystectomy: An Observational Study
NCT06375057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the Ages Of 18-65,
* Least Primary School Graduate,
* Not Using Drugs That May Affect Cognitive Functions,
* Non-Alcohol Substance Use,
* Patients Without Psychiatric and Neurological Disease.
Exclusion Criteria
* Those with an important cardiovascular or central nervous system disease,
* Patients with pain syndromes or routinely using opioid.
Very urgent patients
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bozok University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ökkeş Hakan Miniksar
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ökkeş Hakan Miniksar, Asist.Prof
Role: STUDY_CHAIR
YOZGAT BOZOK UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bozok University Medical Center
Yozgat, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
189_2020.03.25_02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.